Webinar Replay: The Discovery of Target Antigens for Dysfunctional T Cells in ME/CFS and Long COVID
Dr. Liisa Selin, Dr. Ayano Kohlgruber, and Dr. Roshan Kumar received a Solve ME/CFS Catalyst
May 5, 2026
Dr. Liisa Selin, Dr. Ayano Kohlgruber, and Dr. Roshan Kumar received a Solve ME/CFS Catalyst
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we know about
When an organization, like a government agency, company, or nonprofit, considers a big change or
Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the
Dr. Karen Bonuck is professor of family and social medicine at Albert Einstein College of
A quick note to loop you in on another appropriations effort we’re in support of
We’re proud to announce that Solve CEO Emily Taylor has been selected for the 2026–2027
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we can do
Solve M.E. is proud to welcome Dr. Jessica Maya as our new Vice President of
Solve M.E. is proud to support two pioneering studies through our latest round of ME/CFS
In our What’s New in ME/CFS? series, we spotlight researchers transforming what we know –
Solve M.E. is proud to share that our President and CEO, Emily Taylor, has authored